Schonfeld Strategic Advisors LLC Adicet Bio, Inc. Transaction History

Schonfeld Strategic Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.21 - $2.4 $1.34 Million - $2.65 Million	-1,104,800 Reduced 97.39%	29,600 $35,000
Q1 2024 May 15, 2024	BUY	$1.76 - $3.45 $1.64 Million - $3.22 Million	934,300 Added 466.92%	1,134,400 $2.67 Million
Q4 2023 Feb 14, 2024	BUY	$1.11 - $1.89 $222,111 - $378,189	200,100 New	200,100 $378,000
Q2 2023 Aug 14, 2023	BUY	$2.13 - $7.13 $36,849 - $123,349	17,300 New	17,300 $42,000

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $38.8M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.